English
Segment disclosures
Company overviewAVITA Medical, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
5 dimension combinations 55 retained observations 16 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
AU · Foreign
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=country:AU;us-gaap:StatementBusinessSegmentsAxis=rcel:ForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 275000 | USD | 20230223 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 136000 | USD | 20230223 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 207000 | USD | 20230223 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 25000 | USD | 20210513 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 158000 | USD | 20210513 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 53000 | USD | 20210216 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 133000 | USD | 20210216 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 80000 | USD | 20201110 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 292000 | USD | 20210826 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 46000 | USD | 20210513 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 217000 | USD | 20210513 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 125000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 171000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 46000 | USD | 20201110 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 806000 | USD | 20210826 | Open filing evidence |
| 2017-07-01 – 2018-06-30 | 550000 | USD | 20200827 | Open filing evidence |
GB · Foreign
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=country:GB;us-gaap:StatementBusinessSegmentsAxis=rcel:ForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 160000 | USD | 20230223 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 56000 | USD | 20230223 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 70000 | USD | 20230223 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 15000 | USD | 20210513 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 55000 | USD | 20210513 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 30000 | USD | 20210216 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 40000 | USD | 20210216 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 10000 | USD | 20201110 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 171000 | USD | 20210826 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 51000 | USD | 20210513 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 160000 | USD | 20210513 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 35000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 109000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 74000 | USD | 20201110 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 264000 | USD | 20210826 | Open filing evidence |
| 2017-07-01 – 2018-06-30 | 379000 | USD | 20200827 | Open filing evidence |
JP · Foreign
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=country:JP;us-gaap:StatementBusinessSegmentsAxis=rcel:ForeignMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 729000 | USD | 20230223 | Open filing evidence |
Foreign · AU
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rcel:ForeignMember;srt:StatementGeographicalAxis=country:AU| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 57000 | USD | 20221110 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 173000 | USD | 20221110 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 29000 | USD | 20220811 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 116000 | USD | 20220811 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 87000 | USD | 20220512 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 66000 | USD | 20221110 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 141000 | USD | 20221110 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 49000 | USD | 20220811 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 74000 | USD | 20220811 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 25000 | USD | 20220512 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 80000 | USD | 20211108 | Open filing evidence |
Foreign · GB
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=rcel:ForeignMember;srt:StatementGeographicalAxis=country:GB| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 39000 | USD | 20221110 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 121000 | USD | 20221110 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 28000 | USD | 20220811 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 82000 | USD | 20220811 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 54000 | USD | 20220512 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 30000 | USD | 20221110 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 60000 | USD | 20221110 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 15000 | USD | 20220811 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 30000 | USD | 20220811 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 15000 | USD | 20220512 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 10000 | USD | 20211108 | Open filing evidence |